This investigation involves focus groups designed to collect patient opinions about a specific psychotherapy, called START NOW, as well as general beliefs about various elements of psychotherapy for treating opioid use disorder (OUD).
Clinical trials provide consistent evidence for buprenorphine’s efficacy in treating opioid use disorder (OUD). While the Drug Addiction Treatment Act of 2000 requires physicians to combine medication-assisted treatment (MAT) with behavioral intervention, there is no clear evidence for what form or elements of psychotherapy are most effective when coupled with MAT to treat OUD. The authors’ analysis reveals trends about patient preferences and strategies for improving OUD treatment. (Published abstract provided)
Downloads
Similar Publications
- The Cross-Reactivity of the Cannabinoid Analogs (delta-8-THC, delta-10-THC and CBD) and their metabolites in Urine of Six Commercially Available Homogeneous Immunoassays, Grant Report
- Student Violence Against Teachers in Large U.S. School Districts: Prevalence and Risk Factors, Final Report
- VADFS Toxicology Procedure Manual